The immunological relevance of CD8+ TCRαβ cross-reactivity is still a matter of debate (60–63), although seminal studies on potential cross-reactivity of T1D-relevant CD8+ T cell clones for T1D-associated human antigens and pathogens have already been published (28, 64, 65). Here, CD8A is linked to type 1 diabetes mellitus.